Antares Pharma, Inc. (ATRS) Q4 2021 Earnings Conference Call March 3, 2022 8:30 AM ET Company Participants Tram Bui - VP-Corporate Communications and IR Bob Apple - President and CEO Joe Renda - SVP-Commercial Peter Richardson - EVP -Research and Development and Chief Medical Officer Fred Powell - EVP and CFO Conference Call Participants Elliot Wilbur - Raymond James David Amsellem - Piper Sandler Stacy Ku - Cowen and Company Matt Kaplan - Ladenburg Thalmann Greg Fraser - Truist Securities Operator Ladies a ...

4Q and FY 2021 Financial and Operating Results NASDAQ: ATRS | March 3, 2022 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forwardlooking statements are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to: the Company's ability to achieve th ...

Halozyme Confidential and Proprietary 40th Annual J.P. Morgan Healthcare Conference Dr. Helen Torley, President and CEO January 10, 2022 Halozyme Confidential and Proprietary 2 Forward-Looking Statements In addition to historical information, the statements set forth in this presentation include forward-looking statements including, without limitation, statements concerning the Company's expected future financial performance (including financial estimates for 2021 and outlook for 2022) and expectations for ...

9 Halozyme Corporate Presentation November 2021 Forward-Looking Statements 2 In addition to historical information, the statements set forth in this presentation include forward-looking statements including, without limitation, statements concerning the Company's expected future financial performance (including the Company's financial outlook for 2021) and expectations for profitability, revenue (including expectations for future milestones and royalty growth), operating income, cash flow, expenses and earn ...

3Q 2021 Financial and Operating Results NASDAQ: ATRS | November 4, 2021 November 2021 1 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to: the Company's ability ...

Antares Pharma, Inc. (ATRS) Q3 2021 Earnings Conference Call November 4, 2021 8:30 AM ET Company Participants Tram Bui - VP-Corporate Communications and IR Bob Apple - President and CEO Joe Renda - SVP-Commercial Peter Richardson - EVP -Research and Development and Chief Medical Officer Fred Powell - EVP and CFO Conference Call Participants Greg Fraser - Trust Securities Stacy Ku - Cowen and Company David Amsellem - Piper Sandler Elliot Wilbur - Raymond James Anthony Petrone - Jefferies Matt Kaplan - Ladenb ...